FDA Working To Fill Advisory Panel Vacancies While Tightening Conflict-Of-Interest Rules
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's revised draft guidance adds requirement for public disclosure of the company or institution that is the source of a conflict.
You may also be interested in...
Conflict Of Interest Reform: With FDA Undecided, Consumer Groups Give Their Pitch
FDA likes some rules in FDAAA and wants to continue discussion with Capitol Hill as changes are expected to be part of PDUFA legislation.
PDUFA Word Association: Consumer Advocates Complain About Lack Of "Safety" In Commitment Letter
FDA’s Oct. 24 public meeting on the renewal of its drug user fee program demonstrated just how strong a position the agency is in regarding the renewal of the Rx part of the “UFA” legislation – most of the complaints were semantic, quite literally.
PDUFA Word Association: Consumer Advocates Complain About Lack Of "Safety" In Commitment Letter
FDA’s Oct. 24 public meeting on the renewal of its drug user fee program demonstrated just how strong a position the agency is in regarding the renewal of the Rx part of the “UFA” legislation – most of the complaints were semantic, quite literally.